Mesothelioma Misdiagnosis: How Often It Happens and What to Do in 2026

Approximately 14% of mesothelioma diagnoses in well-resourced countries are incorrect, according to a 2023 Journal of Thoracic Oncology study.^[1] In resource-limited settings, that rate approaches 50%. Because pleural mesothelioma shares morphological features with lung adenocarcinoma and peritoneal mesothelioma mimics ovarian cancer, patients face a median diagnostic delay of 6.5 months from symptom onset to specialist referral — and many see three or more doctors before receiving a correct diagnosis.^[2]

What are the key facts about mesothelioma misdiagnosis?

What conditions is mesothelioma most commonly misdiagnosed as?

This cancer mimics a wide range of common conditions because its early symptoms — cough, shortness of breath, chest or abdominal pain, and fatigue — overlap with dozens of more prevalent diseases. The specific misdiagnoses differ between pleural and peritoneal mesothelioma.^[5]

Pleural mesothelioma misdiagnoses

The pleural form, which accounts for approximately 80% of all cases, is most frequently confused with:

• Lung adenocarcinoma: The most common cancer misdiagnosis. Epithelioid cells closely resemble adenocarcinoma cells under standard microscopy, requiring specialized immunohistochemical staining to differentiate.^[1]
• Pneumonia or bronchitis: Overlapping symptoms of cough, dyspnea, and chest pain lead to initial treatment with antibiotics rather than oncology referral.
• COPD: Chronic respiratory symptoms in older patients with smoking history often lead to a COPD diagnosis before imaging reveals pleural abnormalities.
• Pleural effusion of unknown origin: Recurrent fluid drainage without malignant cytology delays recognition of the underlying malignancy.
• Heart disease: Effusion-related symptoms, including chest pressure and shortness of breath, are initially attributed to cardiac causes.

A study published in The Open Epidemiology Journal found that approximately 1 in 4 pleural patients receive an incorrect initial diagnosis.^[7]

Peritoneal mesothelioma misdiagnoses

The peritoneal form is even more challenging to diagnose correctly because it presents with nonspecific abdominal symptoms:

• Ovarian cancer: The most common misdiagnosis in women. Peritoneal implants, ascites, and elevated CA-125 closely mimic advanced ovarian malignancy. Case reports document patients undergoing full debulking surgery under presumed ovarian cancer before the correct diagnosis was identified.^[5]
• Irritable bowel syndrome (IBS): Bloating, abdominal pain, and changes in bowel habits are initially attributed to functional GI disorders.
• Other abdominal cancers: Pancreatic cancer, colon cancer, and peritoneal carcinomatosis of unknown primary are common initial diagnoses.

"I've spoken with hundreds of patients diagnosed with this disease over the years, and the diagnostic journey is almost always the same — months of being told it's something else before anyone considers mesothelioma. Those who mention their asbestos exposure history to every doctor they see tend to get to the right diagnosis faster."

Why do pathology errors occur in mesothelioma?

Pathology-level misdiagnosis is the most consequential type of diagnostic error because it can lead to entirely wrong treatment. The morphological resemblance between epithelioid mesothelioma and adenocarcinoma is the primary source of confusion.^[1]

International pathology error rates

Studies from multiple countries demonstrate the scale of the problem:

Study / Setting	Confirmed Rate	Key Finding
Developed countries (2023 JTO)	86%	14% misdiagnosis rate in well-resourced settings[1]
Resource-limited settings (2023 JTO)	~50%	Up to 50% misdiagnosis rate[1]
France (Goldberg et al., 2006)	67%	Expert panel confirmed 67%, ruled out 13%, uncertain 20%[3]
China (Guo et al., 2017)	56.5%	Only 52 of 92 specimens confirmed; pleural: 35.3%[3]
Brazil (2024 São Paulo)	+12%	Expert review improved diagnostic accuracy by 12%[11]
Japan (pathology review)	85–90%	10–15% receive inadequate diagnosis; 30% of relief applicants rejected[3]

The immunohistochemistry problem

Accurate diagnosis of this malignancy requires a panel of immunohistochemical (IHC) markers. A 2025 review in Cancers found that the primary cause of pathology misdiagnosis was "the use of an incomplete set of immunostains and/or the incorrect interpretation of the stains."^[1] The essential IHC panel includes:

• Calretinin: 80–100% sensitive for epithelioid mesothelioma; negative in lung adenocarcinoma
• WT-1: 70–100% sensitive for mesothelioma
• D2-40 (podoplanin): Positive mesothelioma marker
• Claudin-4: 92–100% sensitivity and 94–100% specificity for carcinoma vs. mesothelioma
• BAP1: Loss of nuclear staining supports mesothelioma diagnosis
• MTAP: Loss correlates with homozygous CDKN2A deletion in mesothelioma

Community hospital labs that lack experience with this full panel — or that rely on only one or two markers — are the most common source of diagnostic error.^[3]

"When a patient tells me they were diagnosed at a community hospital, my first recommendation is always the same: get your slides reviewed at a major cancer center. I've seen too many cases where the initial pathology was wrong because the lab didn't run the full panel of markers. That one step — a pathology second opinion — can change everything."

How does diagnostic delay affect mesothelioma survival?

The consequences of misdiagnosis extend far beyond the emotional toll. Delayed or incorrect diagnosis directly reduces survival by limiting access to curative-intent treatments.^[4]

Stage at diagnosis determines treatment options

The 5-year survival rate for localized pleural disease is approximately 20%, compared to only 8% for distant or advanced stages.^[6] Early-stage patients are candidates for curative-intent surgical options such as pleurectomy/decortication or extrapleural pneumonectomy combined with chemotherapy and immunotherapy. Once diagnosed late, treatment shifts from curative to palliative.^[5]

A Queen's University meta-analysis found that each 4-week delay in cancer surgery increases mortality risk by 6% to 8%. Delayed chemotherapy after surgery raises the risk by up to 13%.^[4] For this cancer, where the treatment window is narrow and the disease progresses rapidly, these delays are especially consequential.

Up to 80% of patients initially thought to be in stages 1 or 2 were upstaged during surgical exploration — meaning the disease had progressed beyond what imaging showed. Less than 20% of patients with delayed diagnoses were eligible for curative-intent surgery in the Gregório et al. study.^[2]

A counterintuitive finding: referral quality matters more than speed alone

A 2024 SEER-based study of 4,879 pleural patients found a paradoxical result: patients with treatment initiation delayed beyond 39 days had better median survival (13 months vs. 10 months).^[4] The researchers attributed this to the fact that longer time-to-treatment reflected referral to specialized high-volume centers for comprehensive staging and multidisciplinary treatment planning. This finding reinforces that where and how patients are treated matters as much as how quickly treatment begins.

How do specialized centers compare to community hospitals for mesothelioma diagnosis?

The evidence strongly supports that diagnostic accuracy differs dramatically between community hospitals and specialized treatment centers experienced with this disease.

Community hospital pathology labs that encounter this malignancy rarely — perhaps once every few years — lack the specimen experience and full IHC panel needed for accurate diagnosis. The Guo et al. study found that even at two reference centers in China, expert review confirmed only 56.5% of submitted diagnoses. The primary reasons were "the use of an incomplete set of immunostains and/or the incorrect interpretation of the stains, as well as an overall tendency to make a definitive diagnosis even when the evidence was inadequate."^[3]

UK British Thoracic Society guidelines recommend that all patients with this diagnosis be reviewed at specialist multidisciplinary team (MDT) meetings, which studies show improve treatment quality, coordination, and evidence-based decision-making. Travel distance to specialist centers has been positively associated with survival in operable pleural mesothelioma — patients who travel farther to reach specialized centers receive higher-quality care despite the logistical burden.^[4]

What are 5 steps to confirm or challenge a mesothelioma diagnosis?

If you or a loved one has received a mesothelioma diagnosis — or suspects a current diagnosis may be incorrect — take these steps immediately:

Step 1: Request your pathology slides and reports. You have a legal right to your medical records. Ask for the original biopsy slides, the pathology report, and all imaging studies. These will be needed for any second opinion.^[9]

Step 2: Seek a second opinion at a specialized center. Contact an NCI-designated cancer center or a hospital with a dedicated mesothelioma program. Institutions like Memorial Sloan Kettering, MD Anderson, Brigham and Women's, and Moffitt Cancer Center have pathologists who review mesothelioma specimens regularly. A 2025 Yale Medicine study found that 21% of patients who sought a second opinion received a completely new diagnosis.^[5]

Step 3: Ensure the full IHC panel is used. Ask the reviewing pathologist to confirm that calretinin, WT-1, D2-40, claudin-4, BAP1, and MTAP were all included in the analysis. An incomplete panel is the most common cause of pathology-level error.^[1]

Step 4: Disclose your asbestos exposure history. Patients who reported prior asbestos exposure had significantly shorter specialist referral times (median 120 days vs. 214 days) in the Gregório et al. study.^[2] Telling every doctor about your exposure history — including occupation, work sites, and time periods — helps clinicians consider mesothelioma earlier in the diagnostic process.

Step 5: Consult a mesothelioma attorney. A misdiagnosis may have delayed your treatment and shortened the statute of limitations window for legal claims. An experienced mesothelioma attorney can evaluate how the diagnostic delay affects your legal options and help you pursue compensation from responsible asbestos manufacturers and employers.^[13]

"The single most important thing a patient can do after a mesothelioma diagnosis is get a second opinion from a specialist center. I've worked with families who were told their loved one had lung cancer, were treated for lung cancer, and only months later learned it was mesothelioma. That lost time can never be recovered — but it can be addressed through the legal system."

Frequently Asked Questions

References

1. Diagnostic Challenges in the Pathological Approach to Pleural Mesothelioma — Lucà et al., Cancers (Basel), 2025
2. Mesothelioma in a developing country: a retrospective analysis of the diagnostic process — Gregório et al., J Bras Pneumol, 2022
3. Improving the Accuracy of Mesothelioma Diagnosis in China — Guo et al., Journal of Thoracic Oncology, 2017
4. Paradoxical Improvement in MPM Outcomes Following Delayed Treatment Initiation — Kulshrestha et al., Cancers, 2024
5. Mesothelioma Treatment (PDQ) — Health Professional Version — National Cancer Institute, 2025
6. SEER Cancer Statistics Explorer: Mesothelioma — National Cancer Institute, 2025
7. Monte Carlo Analysis of Impact of Underascertainment of Mesothelioma Cases — The Open Epidemiology Journal, 2011
8. Mesothelioma Quick Facts — WikiMesothelioma
9. Mesothelioma Diagnosis — WikiMesothelioma
10. Mesothelioma Pathology — WikiMesothelioma
11. Identifying malignant mesothelioma by a pathological survey — São Paulo — Gregório et al., J Pneumologia, 2024
12. Toxicological Profile for Asbestos — Agency for Toxic Substances and Disease Registry, 2024
13. VA Asbestos Exposure and Benefits — U.S. Department of Veterans Affairs, 2025